Senate Special Committee on Aging Chairman Casey Issues Statement on First Set of Lower, Medicare-Negotiated Prescription Drug Prices
August 16, 2024
August 16, 2024
WASHINGTON, Aug. 16 -- Sen. Robert Casey Jr., D-Pennsylvania, chairman of the Senate Special Committee on Aging, issued the following statement on Aug. 15, 2024:
* * *
Today, U.S. Senator Bob Casey (D-PA), Chairman of the U.S. Senate Special Committee on Aging, released the following statement after the Biden Administration announced new, lower costs for the first ten drugs subject to price negotiations by Medicare. The drugs are Eliquis, Jardiance, Xarelto, Januvia, Fa . . .
* * *
Today, U.S. Senator Bob Casey (D-PA), Chairman of the U.S. Senate Special Committee on Aging, released the following statement after the Biden Administration announced new, lower costs for the first ten drugs subject to price negotiations by Medicare. The drugs are Eliquis, Jardiance, Xarelto, Januvia, Fa . . .